Cargando…

Strategies and safety considerations of booster vaccination in COVID-19

The first-generation SARS-CoV-2 vaccines have played a significant role in controlling the COVID-19 pandemic, preventing severe diseases, and reducing mortality. However, the continuous emergence of SARS-CoV-2 variants, the persistence of breakthrough infections, and the seemingly rapid decline in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Hanyan, Mao, Jianhua, Ye, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162749/ https://www.ncbi.nlm.nih.gov/pubmed/35366790 http://dx.doi.org/10.17305/bjbms.2021.7082

Ejemplares similares

Booster Vaccination Strategies for “Living With COVID-19”
por: Kim, Jung Eun, et al.
Publicado: (2022)

Immunological considerations for COVID-19 vaccine strategies
por: Jeyanathan, Mangalakumari, et al.
Publicado: (2020)

Safety of seven COVID-19 vaccine booster doses
Publicado: (2021)

COVID-19 Vaccine Booster: To Boost or Not to Boost
por: Shekhar, Rahul, et al.
Publicado: (2021)

COVID-19 vaccine booster strategy: striving for best practice
por: Tanriover, Mine Durusu, et al.
Publicado: (2022)

Covid-19 Vaccines — Immunity, Variants, Boosters
por: Barouch, Dan H.
Publicado: (2022)

Effectiveness of COVID-19 Vaccine Booster Shot Compared with Non-Booster: A Meta-Analysis
por: Zhu, Yajuan, et al.
Publicado: (2022)

Booster or additional vaccination doses in patients vaccinated against COVID-19
por: García-Botella, Alejandra, et al.
Publicado: (2021)

Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters
por: Burckhardt, Rachel M., et al.
Publicado: (2022)

COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations
por: He, Qian, et al.
Publicado: (2021)

Effectiveness of bivalent mRNA booster vaccines against COVID-19: methodological and public health considerations
por: Stoliaroff-Pepin, Anna, et al.
Publicado: (2023)

Safety and Considerations of the COVID-19 Vaccine Massive Deployment
por: Li, Junwei, et al.
Publicado: (2021)

Safety and Efficacy of the Common Vaccines against COVID-19
por: Liu, Ying, et al.
Publicado: (2022)

COVID-19 Vaccine Booster Strategies for Omicron SARS-CoV-2 Variant: Effectiveness and Future Prospects
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

Updated report of COVID-19 vaccine safety monitoring in Japan: Booster shots and paediatric vaccinations
por: Yamaguchi, Toshihiro, et al.
Publicado: (2022)

Safety and Immunogenicity of the Inactivated COVID-19 Vaccine Booster in People Living with HIV in China
por: Yi, Yunyun, et al.
Publicado: (2023)

Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population: A Modeling Study
por: Massonnaud, Clément R., et al.
Publicado: (2022)

Homologous and Heterologous Covid-19 Booster Vaccinations
por: Atmar, Robert L., et al.
Publicado: (2022)

Predicting COVID‐19 booster vaccine intentions
por: Hagger, Martin S., et al.
Publicado: (2022)

Booster vaccines for COVID-19 vaccine breakthrough cases?
por: Nixon, Douglas F, et al.
Publicado: (2022)

Tree-based data mining for safety assessment of first COVID-19 booster doses in the Vaccine Safety Datalink
por: Katherine Yih, W., et al.
Publicado: (2023)

Number needed to vaccinate for COVID-19 booster doses: a valuable metric to inform vaccination strategies
por: Feng, Shuo, et al.
Publicado: (2023)

COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose
por: Dreyer-Alster, Sapir, et al.
Publicado: (2022)

Booster COVID-19 Vaccines for Immune-Mediated Inflammatory Disease Patients: A Systematic Review and Meta-Analysis of Efficacy and Safety
por: Lee, Ainsley Ryan Yan Bin, et al.
Publicado: (2022)

COVID-19-booster vaccine-induced encephalitis
por: Sluyts, Yasmine, et al.
Publicado: (2022)

Omicron variant and booster COVID-19 vaccines
por: Burki, Talha Khan
Publicado: (2022)

COVID-19 Vaccine Booster-Induced Dermatographism
por: Amjad, Mohammad A, et al.
Publicado: (2022)

COVID-19 vaccine equity and booster doses
por: The Lancet Infectious Diseases
Publicado: (2021)

Considerations for vaccinating children against COVID-19
por: Hart, John D, et al.
Publicado: (2023)

Booster Vaccination: The Role of Reduced Antigen Content Vaccines as a Preschool Booster
por: Gabutti, Giovanni, et al.
Publicado: (2014)

Safety assessment of adjuvanted vaccines: Methodological considerations
por: Da Silva, Fernanda Tavares, et al.
Publicado: (2015)

Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial
por: Omma, Ahmet, et al.
Publicado: (2022)

COVID-19 Vaccine Booster Dose Acceptance: Systematic Review and Meta-Analysis
por: Abdelmoneim, Shaimaa Abdelaziz, et al.
Publicado: (2022)

Vaccine and Psychological Booster: Factors Associated With Older Adults’ Compliance to the Booster COVID-19 Vaccine in Israel
por: Ben-David, Boaz M., et al.
Publicado: (2022)

Considerations on the Booster RF accelerating stations
por: Nassibian, G
Publicado: (1968)

Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China
por: Zhou, Hui Jun, et al.
Publicado: (2022)

Myopericarditis After COVID-19 Booster Dose Vaccination
por: Sharff, Katie A., et al.
Publicado: (2022)

COVID-19 Vaccine Boosters: The Good, the Bad, and the Ugly
por: Rzymski, Piotr, et al.
Publicado: (2021)

Herpes Zoster Following COVID-19 Vaccine Booster
por: Shahrudin, Muhammad Shah, et al.
Publicado: (2023)

Insight in booster COVID-19 vaccine and disease modifying therapy in multiple sclerosis
por: Beard, Katherine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i0gv32lfp0e1jn4ob8lt7hsc55